Cargando…
Identification and Characterization of a Suite of Tumor Targeting Peptides for Non-Small Cell Lung Cancer
Tumor targeting ligands are emerging components in cancer therapies. Widespread use of targeted therapies and molecular imaging is dependent on increasing the number of high affinity, tumor-specific ligands. Towards this goal, we biopanned three phage-displayed peptide libraries on a series of well-...
Autores principales: | McGuire, Michael J., Gray, Bethany Powell, Li, Shunzi, Cupka, Dorothy, Byers, Lauren Averett, Wu, Lei, Rezaie, Shaghayegh, Liu, Ying-Horng, Pattisapu, Naveen, Issac, James, Oyama, Tsukasa, Diao, Lixia, Heymach, John V., Xie, Xian-Jin, Minna, John D., Brown, Kathlynn C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3967199/ https://www.ncbi.nlm.nih.gov/pubmed/24670678 http://dx.doi.org/10.1038/srep04480 |
Ejemplares similares
-
A Liposomal Drug Platform Overrides Peptide Ligand Targeting to a Cancer Biomarker, Irrespective of Ligand Affinity or Density
por: Gray, Bethany Powell, et al.
Publicado: (2013) -
Selecting Reliable mRNA Expression Measurements Across Platforms Improves Downstream Analysis
por: Tong, Pan, et al.
Publicado: (2016) -
Tumor-specific intracellular delivery: peptide-guided transport of a catalytic toxin
por: Allred, Curtis A., et al.
Publicado: (2023) -
Dimerization of a Phage-Display Selected Peptide for Imaging of α(v)β(6)- Integrin: Two Approaches to the Multivalent Effect
por: Singh, Ajay N., et al.
Publicado: (2014) -
Integrative proteomic and transcriptomic analysis provides evidence for TrkB (NTRK2) as a therapeutic target in combination with tyrosine kinase inhibitors for non-small cell lung cancer
por: Gomez, Daniel Richard, et al.
Publicado: (2018)